Daily Bulletin

The Times Real Estate

.

Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

BAGSVÆRD, Denmark, Nov. 6, 2020 /PRNewswire/ -- Results of a phase 3a trial showed that investigational drug semaglutide 2.4 mg once-weekly subcutaneous as an adjunct to intensive behavioural therapy (IBT) demonstrated significantly more body weight loss compared to placebo plus IBT.[i] The STEP 3 phase 3a trial investigated the...

Read more: Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to...

Business News

Maintaining Garden Aesthetics Year-Round: Seasonal Gardening for Killara Businesses

Seasonal gardening gives Killara businesses the chance to have beautiful outside areas all year round. Landscaping strategies are changed during the different seasons to help plants grow well in cha...

Daily Bulletin - avatar Daily Bulletin

Site Survey: The Foundation of Successful Construction Projects

A site survey (or land survey) is an essential early step in establishing the requirements for the successful execution and planning of construction and land development. It is a large-scale process...

Daily Bulletin - avatar Daily Bulletin

Why Brite Storage Tanks Are a Game-Changer for Your Beverage Production

Whether you’re brewing a refreshing pale ale or perfecting your cider, every step shapes the final product. That’s where brite storage tanks truly shine. Crafting beverages Australians love takes mor...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals